...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of Clinical and Diagnostic Research >Epitheloid Angiosarcoma of Liver A Hanging Tumour
【24h】

Epitheloid Angiosarcoma of Liver A Hanging Tumour

机译：肝脏上皮胰腺癌悬垂的肿瘤

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Primary Epitheloid Angiosarcoma (EA) of liver is an aggressive malignant tumour with poor prognosis irrespective of aggressivesurgical resection with or without adjuvant therapy. It constitutes for 0.1-2% of primary malignant tumours of liver and is seencommonly in sixth or seventh decade of life, with male preponderance. It can be asymptomatic or may present with nonspecificsymptoms. Lack of pathognomonic features on serological, biochemical and radiological tests, makes it even difficult for an earlydiagnosis. Despite early surgical removal, EA has very high recurrence rate. Chemotherapy agents (paclitaxel, bevacizumab) andimmunomodulators (mTOR inhibitors) have shown some survival benefit and reduction in recurrence rates in recent years asadjuvant therapy.To the best of our knowledge, a hanging morphological variant of EA of liver has not been reported yet in literature. We reporta case of incidentally diagnosed aggressive, hanging variant of EA of liver. Despite early surgical resection and adjuvant, afterchemotherapy patient had survival of less than eight months since first presentation.
机译：肝脏的主要上皮癌症（EA）是一种侵略性恶性肿瘤，其预后不高兴，无论有或没有佐剂治疗。它构成了肝脏原发性恶性肿瘤的0.1-2％，并且在六个或第七十年的生命中被视为雄性优势。它可以是无症状的，或者可以存在非玻璃纤维素。缺乏血清学，生物化学和放射性测试的病例特征，使得早期诊断甚至难以。尽管早期手术切除，EA具有非常高的复发率。化疗剂（紫杉醇，Bevacizumab）Andimmunomomodulators（MTOR抑制剂）显示出近年来asadjuvant治疗的一些生存效益和复发率的复发率降低。对于我们所知，肝脏的悬浮形态变异尚未在文学中报告。我们始终诊断出肝脏肝硬化，肝脏的垂直变种的病例。尽管早期手术切除和佐剂，后期疗法患者患者的存活率少于八个月以来。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号